REQUEST A DEMO
Total
USD $0.00
Search more companies

Tibet Rhodiola Pharmaceutical Holding Co. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tibet Rhodiola Pharmaceutical Holding Co. Profile Updated: October 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

The company is the first listed high-tech pharmaceutical enterprise on the snow Tibetan plateau, is recognized as National Torch Plan Key High-tech enterprise by the Ministry of Science, owns six subsidiaries: Tibet Nuodikang Pharmaceutical Co., Ltd., Sichuan Nuodikang Weiguang Pharmaceuticals Co., Ltd., Tibet Kangda Pharmaceutical Co., Ltd., Tibet Nuodikang Tibetan medicine Development Co., Ltd., Chengdu Nuodikang bio-pharmaceutical Co., Ltd., Sichuan Noah Medical Technology Co., Ltd., an Institute and the Chinese Academy of Sciences Nuodi Tibetan medicine modern research center. The company main products include Nuodikang capsule, Shiwei Dida capsules, Snow Jin Luohan pain Plaster, children double Granule.

Headquarters
No. 3, Guangzhou Road, Area A, Lhasa Economic and Technological Development Zone, Lhasa, Lhasa, Tibet, No. 427, Sanse Road, Jinjiang District, Chengdu, Sichuan Province
Guangzhou; Guangdong; Postal Code: 850000

Contact Details: Purchase the Tibet Rhodiola Pharmaceutical Holding Co. report to view the information.

Website: http://www.xzyy.cn

Basic Information
Total Employees:
Purchase the Tibet Rhodiola Pharmaceutical Holding Co. report to view the information.
Outstanding Shares:
Purchase the Tibet Rhodiola Pharmaceutical Holding Co. report to view the information.
Registered Capital:
Purchase the Tibet Rhodiola Pharmaceutical Holding Co. report to view the information.
Financial Auditors:
Purchase the Tibet Rhodiola Pharmaceutical Holding Co. report to view the information.
Incorporation Date:
July 14, 1999
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
32.28%
Purchase this report to view the information.
17.78%
Purchase this report to view the information.
3.19%
Purchase this report to view the information.
3.11%
Purchase this report to view the information.
1.99%
Subsidiaries
Chengdu Nuodikang Biopharmaceutical Co., Ltd.
100%
Shanghai Haiji Biomedical Engineering Co., Ltd.
100%
Shanghai Xinhuo Biological Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Tibet Rhodiola Pharmaceutical Holding Co. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-8.13%
Total operating revenue
-8.52%
Operating profit (EBIT)
-7.36%
Net Profit (Loss) for the Period
-7.92%
Total assets
-1.07%
Total equity
6.31%
Operating Profit Margin (ROS)
0.34%
Net Profit Margin
0.08%
Return on Equity (ROE)
-3.36%
Debt to Equity Ratio
-7.5%
Quick Ratio
0.81%
Cash Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?